Trainee (Pharmacokinetic Studies Of Biosimilars In Trial Registries: Retrieval And Evaluation)

About the traineeship programme

The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.

Placement description

We are looking for a trainee in the Scientific Advice Office.

Specific objectives and projects

The successful candidate will conduct research, under the supervision and guidance of experienced colleagues, through public clinical trial registries and internal EMA regulatory resources on the development of biosimilar medicines, leading to a publication. Biosimilars have been introduced to lower the price of original biologics. However, hardly any independent research is published on how biosimilars are developed. One of the most contentious issues in the regulation of biosimilars is the link between structural and functional characteristics of the pharmaceutically active protein on the one side, and clinical efficacy and safety of the authorised biosimilar medical product on the other side. In their decision-making, regulators mostly rely on information from biosimilar developments that have reached a marketing authorisation application (MAA) stage. The goal of the research is to identify comparative biosimilar pharmacokinetic (PK) studies in a comprehensive manner, understand what portion of these studies meet their primary PK endpoints, what portion have reached an MAA stage in the EU and how information on the quality attributes, that underpin regulatory decisions to start the PK comparability study, can be retrieved from the registry records. The trainee will develop the core data sheet using multiple methodologies including supervised machine learning, contribute to interpretation of the results, and is expected to become one of the authors on a peer-reviewed publication.

Learning outcomes

Eligibility criteria

• enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;

• possess a university degree in clinical pharmacology, biomedical sciences, or any other life sciences (minimum of three years or more) that must have been obtained between 6 May 2025 and 6 May 2026 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.

• a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.

Additional skills

Strong analytical skills; diligent and systematic approach to work; high attention to detail; and a solid understanding of scientific methodology.

Behavioural Competencies

You will demonstrate the following behavioural competencies:

Conditions of traineeship

The traineeship is offered for 10 months (1 October 2026 – 31 July 2027) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.

The Agency pays a monthly stipend of €2,049.77 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.

Each trainee will have a mentor at the Agency who will guide the trainee through the programme.

The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA

Expected selection timelines